It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Postural orthostatic tachycardia syndrome (POTS) is defined as the development of orthostatic symptoms associated with a rapid (within 10 minutes) increase in heart rate by more than 30 beats per minute or to a heart rate that exceeds 120 beats per minute without orthostatic hypotension. The symptoms of orthostatic intolerance are due to brain hypoper fusion and sympathetic overaction. Patients are usually female and aged 15 to 50 years. POTS represents a category of disease rather than a single distinct illness. Patients with POTS can experience difficulty with daily routines including housework, shopping, eating, and attending work or school. Reports of patients with “POTS-like symptoms” have been made for over 100 years.
The pathophysiologic mechanisms of POTS include peripheral denervation, β-receptor supersensitivity, hypovolemia and impaired cerebral auto regulation. Prolonged deconditioning may also interact with these mechanisms to exacerbate symptoms. Although 3 types of POTS (low-flow, normal-flow, and high-flow POTS) have been distinguished based on differences in peripheral blood flow and peripheral arterial resistance, thoracic hypovolemia is the common final pathophysiologic mechanism.
Therapies are directed at relieving the central hypovolemia or at compensating for the circulatory dysfunctions. Treatments include use of water, saline infusion, α-agonists, β-antagonists, and other agents that may correct the central hypovolemia. These have resulted in varying degrees of success, and they are often used in combination.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan